AxoGen, Inc. (AXGN)

5,75 -0,23 (-3,85%) Al cierre: 04:00PM EDT

AxoGen, Inc.

13631 Progress Boulevard
Suite 400
Alachua, FL 32615
United States
386 462 6800
https://www.axogeninc.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 426

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Karen Zaderej	Chairman, President & CEO	1,49M	N/A	1962
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.	Chief Financial Officer	509,68k	N/A	1975
Mr. Erick DeVinney	Chief Innovation Officer	557,9k	N/A	1976
Mr. Todd Puckett	Vice President of Operations	N/A	N/A	N/A
Mr. Harold D. Tamayo	Vice President of Finance & Investor Relations	N/A	N/A	N/A
Mr. Marc A. Began	Executive VP, General Counsel & Chief Compliance Officer	N/A	N/A	1968
Ms. Doris Quackenbush	Vice President of Sales	N/A	N/A	N/A
Mr. Jens Schroeder Kemp	Chief Marketing Officer	N/A	N/A	N/A
Dr. Ivica Ducic M.D., Ph.D.	Chief Medical Officer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Gobierno corporativo

El ISS Governance QualityScore de AxoGen, Inc., a día 1 de mayo de 2024, es 3. Las puntuaciones base son Auditoría: 1; Tablero: 5; Derechos de los accionistas: 1; Compensación: 6.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.